prednisone has been researched along with crizotinib in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Beuthien-Baumann, B; Bornhäuser, M; Ehninger, G; Kroschinsky, F; Middeke, JM; Ordemann, R; Platzbecker, U; Platzek, I; Stöhlmacher, J; van den Hoff, J; Zietz, C | 1 |
| Brindel, A; Huet, D; Tiotiu, A; Vaillant, P; Vignaud, JM | 1 |
| Chen, H; Guan, J; Li, X; Wu, W; Wu, Y; Zhang, J; Zhang, K | 1 |
3 other study(ies) available for prednisone and crizotinib
| Article | Year |
|---|---|
Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantation.
Topics: Adult; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Carmustine; Cisplatin; Combined Modality Therapy; Compassionate Use Trials; Crizotinib; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Immunoconjugates; Lymphocyte Transfusion; Lymphoma, Large-Cell, Anaplastic; Male; Melphalan; Molecular Targeted Therapy; Neoplasm Proteins; Peripheral Blood Stem Cell Transplantation; Prednisone; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Receptor Protein-Tyrosine Kinases; Remission Induction; Respiration, Artificial; Respiratory Insufficiency; Transplantation, Homologous; Vincristine | 2013 |
[ROS-1 rearranged bronchopulmonary adenocarcinoma revealed by a pulmonary miliary].
Topics: Adenocarcinoma; Adult; Crizotinib; Female; Gene Rearrangement; Glucocorticoids; Humans; Lung Neoplasms; Multiple Pulmonary Nodules; Prednisone; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Pyrazoles; Pyridines | 2018 |
Organizing pneumonia in ALK+ lung adenocarcinoma treated with ceritinib: A case report and literature review.
Topics: Adenocarcinoma of Lung; Anaplastic Lymphoma Kinase; Antineoplastic Agents; Biopsy; Brain Neoplasms; Crizotinib; Cryptogenic Organizing Pneumonia; Drug Substitution; Enzyme Inhibitors; Female; High-Throughput Nucleotide Sequencing; Humans; Lung; Lung Neoplasms; Middle Aged; Pemetrexed; Prednisone; Pyrimidines; Sulfones; Tomography, X-Ray Computed; Treatment Outcome | 2021 |